ARCHIVES

Avastin May Trigger Two FDA Decisions: One On Approval, Another On Withdrawal

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004

NCI To Offer Expanded Access To Oxaliplatin

May 31, 2002

With $1.1 Billion At Stake, Cancer Groups Mull Comparative Effectiveness Studies

May 22, 2009

St. Jude Considers Relocating to Washington U.

August 9, 1985

Gramm-Rudman Cut Facing NCI Could Take $85 Million

October 20, 1989

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012